期刊
CURRENT UROLOGY REPORTS
卷 20, 期 6, 页码 -出版社
SPRINGER
DOI: 10.1007/s11934-019-0893-5
关键词
Overactive bladder (OAB); Urinary urgency; Combination therapy for OAB
Overactive bladder syndrome (OAB) negatively affects the quality of life of patients and their interactions with society. Treatment of OAB starts with behavioral modification and then pharmacotherapy using monotherapy with either antimuscarinics or 3 agonists. The third-line more invasive approaches are the next treatment option currently recommended. Both antimuscarinic agents and 3 agonists work through a different molecular pathway. This brings up the potential of having an additive effect when using a combination treatment for patients with OAB. Currently, the potential for using combination therapy to treat OAB in patients who had no improvement with a monotherapy approach before we attempt a more invasive approach is being explored. Several studies have shown the benefits of combination therapy which will be an additional option to the tools to treat OAB.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据